Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5-Reference-Cited by-同舟云学术

Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5

Published:2006-12 Issue:12 Volume:97 Page:1374-1380
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Tsukahara Tomohide,Kawaguchi Satoshi,Torigoe Toshihiko,Asanuma Hiroko,Nakazawa Emiri,Shimozawa Kumiko,Nabeta Yuki,Kimura Shigeharu,Kaya Mitsunori,Nagoya Satoshi,Wada Takuro,Yamashita Toshihiko,Sato Noriyuki

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2006.00317.x/fullpdf

Reference42 articles.

1. Common Musculoskeletal Tumors of Childhood and Adolescence

2. Management of soft-tissue sarcomas: an overview and update

3. Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

4. Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups

5. A Clinical Trial of Autogenous Vaccines in the Treatment of Osteogenic Sarcoma

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disruptions in antigen processing and presentation machinery on sarcoma;Cancer Immunology, Immunotherapy;2024-09-09

2. Impact of disruptions in antigen processing and presentation machinery on sarcoma;2024-07-12

3. Assessment of cancer cell‐expressed HLA class I molecules and their immunopathological implications;HLA;2024-05

4. Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers;Frontiers in Immunology;2024-01-22

5. Impact of disruptions in antigen processing and presentation machinery on sarcoma;2023-12-01